Welcome to our dedicated page for Retractable Tech news (Ticker: RVP), a resource for investors and traders seeking the latest updates and insights on Retractable Tech stock.
Retractable Technologies Inc. (RVP) delivers critical safety solutions through its innovative medical devices, including patented safety syringes that address global healthcare challenges. This news hub provides investors and healthcare professionals with timely updates on corporate developments, regulatory milestones, and market positioning in the medical device sector.
Access authoritative reporting on RVP's financial performance, product innovations, and compliance achievements. Our curated news collection features earnings announcements, manufacturing expansions, and partnerships that demonstrate the company's commitment to infection prevention and medical device safety.
Key updates include quarterly financial disclosures, FDA clearance announcements, international distribution agreements, and advancements in syringe safety technology. Bookmark this page for structured access to press releases and analysis that matter most to stakeholders in medical innovation and healthcare safety.
Retractable Technologies, Inc. (AMEX: RVP) announced dividends for its Series II and Series III Class B Convertible Preferred Stock, totaling
Retractable Technologies, Inc. (AMEX: RVP) reported a 49.7% decrease in revenues for 2022, totaling approximately
Retractable Technologies, Inc. (NYSE American: RVP) has announced a workforce reduction of about 22% due to decreased domestic production needs. This decision primarily impacts the production, operations, and logistics departments, aiming for an annual savings of approximately $1.7 million, which is about 13% of its payroll expenses. The expected separation costs are around $154,000. Despite the workforce cut, the company is confident it can maintain its domestic production capacity to meet current demands.
Retractable Technologies, Inc. (RVP) has announced a plan to repurchase 3 million shares of its common stock from BML Investment Partners at $1.60 per share, an 8% discount from the last closing price of $1.74 on December 22, 2022. The company views this repurchase as advantageous due to the stock’s low price, enhancing shareholder value. This strategic move could positively impact earnings per share (EPS) by reducing the total shares outstanding, thereby potentially increasing the stock price in the future.
Retractable Technologies, Inc. (NYSE American: RVP) has declared dividends for holders of its Series II and Series III Class B Convertible Preferred Stock, amounting to $39,050.00 and $19,061.25, respectively. These dividends, accrued at $1.00 per share per annum, cover the period from October 1, 2022 to December 31, 2022. Payment is scheduled for January 20, 2023, to shareholders on record as of January 10, 2023. Retractable manufactures safety medical products designed to prevent needlestick injuries and bloodstream infections.